The new drug approvals of 1996, 1997, & 1998:: Drug development trends in the user fee era.

被引:0
|
作者
Kaitin, KI [1 ]
Healy, EM [1 ]
机构
[1] Tufts Univ, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA
关键词
D O I
10.1016/S0009-9236(99)80229-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PII111
引用
收藏
页码:174 / 174
页数:1
相关论文
共 50 条
  • [21] Trends in new drug approvals in 2021 and the GuidetoPharmacology.org database
    Alexander, Steve
    Armstrong, Jane
    Cao, Huayu
    Davenport, Anthony
    Davies, Jamie
    Faccenda, Elena
    Harding, Simon
    Southan, Chris
    Spedding, Michael
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (04) : 542 - 543
  • [22] FDA and Industry Move to Renew New Drug User Fee Programs
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2021, 34 (05) : 8 - 9
  • [23] Fda and industry move to renew new drug user fee programs
    Wechsler, Jill
    Pharmaceutical Technology, 2021, 45 (05) : 14 - 15
  • [24] WHATEVER HAPPENED TO USER FEES AND THE FDAS PROMISE TO EXPEDITE NEW DRUG APPROVALS
    GATTY, B
    HOSPITAL FORMULARY, 1993, 28 (07): : 656 - &
  • [25] FDA and drug safety: New tufts study challenges critics of the Prescription Drug User Fee Act
    Lee, R
    JOURNAL OF LAW MEDICINE & ETHICS, 2006, 34 (01): : 131 - 134
  • [26] Effect of research and development outsourcing on new drug approvals in the pharmaceutical industry
    Banerjee, Tannista
    Nayak, Arnab
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2013, 4 (01) : 51 - 56
  • [27] Abbreviated New Drug Applications: Generic Drug User Fee Amendments Act Analysis of Application Quality Metrics
    Woo, Jason
    Luan, Jingyu
    Li, Zili
    Grosser, Stella
    Peters, John
    Chazin, Howard
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (05) : 696 - 700
  • [28] New Era for Novel CNS Drug Development
    William Z Potter
    Neuropsychopharmacology, 2012, 37 : 278 - 280
  • [29] Target-Driven Tissue-Agnostic Drug Approvals-A New Path of Drug Development
    Thein, Kyaw Z.
    Myat, Yin M.
    Park, Byung S.
    Panigrahi, Kalpana
    Kummar, Shivaani
    CANCERS, 2024, 16 (14)
  • [30] New Era for Novel CNS Drug Development
    Potter, William Z.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) : 278 - 280